Hepatic encephalopathy: A dynamic or static condition

Metabolic Brain Disease

Volumn 20, Issue 3, 2005, Pages 193-204

  Stewart, Charmaine A ^a   Cerhan, Jane ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

Cirrhosis; Cognition in liver disease; Cognitive dysfunction in liver diseases; Decompensated liver disease; Hepatic encephalopathy; Portosystemic encephalopathy

Indexed keywords

AMMONIA; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; GLUCOSE; GLUTAMATE SYNTHASE; GLUTAMIC ACID; GUANOSINE PHOSPHATE; MANGANESE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OXYGEN; REACTIVE OXYGEN METABOLITE; SEROTONIN;

ALZHEIMER DISEASE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN METABOLISM; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTROENCEPHALOGRAM; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HOMEOSTASIS; HUMAN; HUNTINGTON CHOREA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MEMORY; MENTAL DISEASE; METABOLIC RATE; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOGENESIS; PORTOSYSTEMIC ANASTOMOSIS; PSYCHOLOGICAL THEORY; REVIEW; SEROTONINERGIC TRANSMISSION; SLEEP WAKING CYCLE;

COGNITION DISORDERS; GLUTAMIC ACID; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; REACTIVE OXYGEN SPECIES; SYNAPTIC TRANSMISSION;

EID: 25144474538     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-005-7207-x     Document Type: Review

References (76)

1. Aguilar, M.A., Minarro, J., and Felipo, V. (2000). Chronic moderate hyperammonemia impairs active and passive avoidance behavior and conditional discrimination learning in rats. Exp. Neurol. 161(2):704-713.
2. al Mardini, H., Harrison, E.J., Ince, P.G., Bartlett, K., and Record, C.O. (1993). Brain indoles in human hepatic encephalopathy. Hepatology 17(6):1033-1040.
3. Anholt, R.R., Pedersen, P.L., De Souza, E.B., and Snyder, S.H. (1986). The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J. Biol. Chem. 261(2):576-583.
4. Bengtsson, F., Bugge, M., Johansen, K.H., and Butterworth, R.F. (1991). Brain tryptophan hydroxylation in the portacaval shunted rat: A hypothesis for the regulation of serotonin turnover in vivo. J. Neurochem. 56:1069-1074.
5. Bergeron, M., Reader, T.A., Layrargues, G.P., and Butterworth, R.F. (1989). Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem. Res. 14(9):853-859.
6. Blei, A. T. (1996). Brain edema - ITs relation to hepatic encephalopathy. In (C. Record and H. Al-Mardini, eds.), Advances in Hepatic Encephalopathy and Metabolism in Liver Disease, Newcastle Upon Tyne, Medical Faculty of Newcastle Upon Tyne, pp. 1259-1266.
7. Bruck, R., Aeed, H., Shirin, H., Matas, Z., Zaidel, L., Avni, Y., and Halpern, Z. (1999). The hydroxyl radical scavengers dimethylsulfoxide and dimethylthiourea protect rats against thioacetamide-induced fulminant hepatic failure. J. Hepatol. 31:27-38.
8. Burkhard, P.R., Delavelle, J., Du Pasquier, R., and Spahr, L. (2003). Chronic parkinsonism associated with cirrhosis: A distinct subset of acquired hepatocerebral degeneration. Arch. Neurol. 60(4):521-528.
9. Butterworth, R.F. (1998). Alterations of neurotransmitter-related gene expression in human and experimental portal-systemic encephalopathy. Metab Brain Dis. 13(4):337-349.
10. Chan, H., and Butterworth, R.F. (1999). Evidence for an astrocytic glutamate transporter deficit in hepatic encephalopathy. Neurochem. Res. 24(11):1397-1401.
11. Ciancio, A., Marchet, A., Saracco, G., Carucci, P., Lavezzo, B., Leotta, D., Capellero, B., Nobili, M., Smedile, A., and Rizzetto, M. (2002). Spectral electroencephalogram analysis in hepatic encephalopathy and liver transplantation. Liver Transpl. 8(7):630-635.
12. Collingridge, G., and Bliss, T. (1987). NMDA receptors-their role in long-term potentiation. Trends Neurosci. 10:288-293.
13. Conn, H., and Lieberthal, M.M. (1979). The Hepatic Coma Syndromes and Lactulose, Lippincott Williams & Wilkins, Baltimore.
14. Corbalan, R., Hernandez-Viadel, M., Llansola, M., Montoliu, C., and Felipo, V. (2002). Chronic hyperammonemia alters protein phosphorylation and glutamate receptor-associated signal transduction in brain. Neurochem. Int. 41(2/3):103-108.
15. Cordoba, J., Alonso, J., Rovira, A., Jacas, C., Sanpedro, F., Castells, L., Vargas, V., Margarit, C., Kulisewsky, J., Esteban, R., and Guardia, J. (2001). The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J. Hepatol. 35(5):598-604.
16. Dugovic, C., Wauquier, A., Leysen, J. E., Marrannes, R., and Janssen, P.A. (1989). Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat. Psychopharmacology (Berl) 97(4):436-442.
17. Ferenci, P., Lockwood, A., Mullen, K., Tarter, R., Weissenborn, K., Blei, A.T., and members of the Working Party (2002). Hepatic encephalopathy- Definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35(3):716-721.
18. Gilberstadt, S.J., Gilberstadt, H., Zieve, L., Buegel, B., Collier, R. O., Jr., and McClain, C.J. (1980). Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch. Intern. Med. 140(4):519-521.
19. Gross, C.R., Malinchoc, M., Kim, W.R., Evans, R.W., Wiesner, R.H., Petz, J.L., Crippin, J.S., Klintmalm, G.B., Levy, M.F., Ricci, P., Therneau, T.M., and Dickson, E.R. (1999). Quality of life before and after liver transplantation for cholestatic liver disease. Hepatology 29(2):356-364.
20. Guerrini, V.H. (1994). Effect of antioxidants on ammonia induced CNS-renal pathobiology in sheep. Free Radic. Res. 21(1):35-43.
21. Hermenegildo, C., Montoliu, C., Llansola, M., Munoz, M.D., Gaztelu, J.M., Minana, M.D., and Felipo, V. (1998). Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo. Eur. J. Neurosci. 10(10):3201-3209.
22. Hertz, L., and Bender, A. (1993). Astrocytic benzodiazepine receptors: Their possible role in the regulation of brain excitability. In (H. Kimelberg, ed.), Glial Cell Receptors, Raven Press, New York, pp. 159-181.
23. Hertz, L., Yu, A.C., Kala, G., and Schousboe, A. (2000). Neuronal-astrocytic and cytosolic-mitochondrial metabolite trafficking during brain activation, hyperammonemia and energy deprivation. Neurochem. Int. 37(2/3):83-102.
24. Hockerstedt, K., Kajaste, S., Isoniemi, H., Muuronen, A., Raininko, R., Seppalainen, A.M., and Hillbom, M. (1990). Tests for encephalopathy before and after liver transplantation. Transpl. Proc. 22(4):1576-1578.
25. Ilsley, J.E., Moffoot, A.P., and O'Carroll, R.E. (1995). An analysis of memory dysfunction in major depression. J. Affect Disord. 35(1/2):1-9.
26. Jayakumar, A.R., Panickar, K.S., and Norenberg, M.D. (2002). Effects on free radical generation by ligands of the peripheral benzodiazepine receptor in cultured neural cells. J. Neurochem. 83(5):1226-1234.
27. Jayakumar, A.R., Rama Rao, K.V., Schousboe, A., and Norenberg, M.D. (2004). Glutamine-induced free radical production in cultured astrocytes. Glia 46(3):296-301.
28. Kaneko, T., Shigemoto, R., and Mizuno, N. (1988). Metabolism of glutamate and ammonia in astrocyte: An immunocytochemical study. Brain Res. 457(1):160-164.
29. Karam, V., Castaing, D., Danet, C., Delvart, V., Gasquet, I., Adam, R., Azoulay, D., Samuel, D., and Bismuth, H. (2003). Longitudinal prospective evaluation of quality of life in adult patients before and one year after liver transplantation. Liver. Transpl. 9(7):703-711.
30. Larsen, F.S., Olsen, K.S., Ejlersen, E., Hansen, B.A., Paulson, O.B., and Knudsen, G.M. (1995). Cerebral blood flow autoregulation and transcranial Doppler sonography in patients with cirrhosis. Hepatology 22(3):730-736.
31. Layrargues, G.P., Shapcott, D., Spahr, L., and Butterworth, R.F. (1995). Accumulation of manganese and copper in pallidum of cirrhotic patients: Role in the pathogenesis of hepatic encephalopathy? Metab. Brain Dis. 10(4):353-356.
32. Lazeyras, F., Spahr, L., DuPasquier, R., Delavelle, J., Burkhard, P., Hadengue, A., Hochstrasser, D., Mentha, G., Giostra, E., Terrier, F., and Vingerhoets, F. (2002). Persistence of mild parkinsonism 4 months after liver transplantation in patients with preoperative minimal hepatic encephalopathy: A study on neuroradiological and blood manganese changes. Transpl. Int. 15(4):188-195.
33. Lockwood, A.H., Yap, E.W., and Wong, W.H. (1991). Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J. Cereb. Blood Flow Metab. 11(2):337-341.
34. Macdonald, G.A., Frey, K.A., Agranoff, B.W., Minoshima, S., Koeppe, R.A., Kuhl, D.E., Shulkin, B.L., and Lucey, M.R. (1997). Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy. Hepatology 26(2):277-282.
35. Magistretti, P.J., Pellerin, L., Rothman, D.L., and Shulman, R.G. (1999). Energy on demand. Science 283(5401):496-497.
36. Mattarozzi, K., Stracciari, A., Vignatelli, L., D'Alessandro, R., Morelli, M.C., and Guarino, M. (2004). Minimal hepatic encephalopathy: Longitudinal effects of liver transplantation. Arch. Neurol. 61(2):242-247.
37. McCrea, M., Cordoba, J., Vessey, G., Blei, A.T., and Randolph, C. (1996). Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch. Neurol. 53(8):758-763.
38. Mechtcheriakov, S., Graziadei, I.W., Mattedi, M., Bodner, T., Kugener, A., Hinterhuber, H.H., Marksteiner, J., and Vogel, W. (2004). Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation. Liver Transpl. 10(1):77-83.
39. Moore, K.A., Mc, L.J.R., and Burrows, G.D. (2000). Quality of life and cognitive function of liver transplant patients: A prospective study. Liver Transpl. 6(5):633-642.
40. Moss, H.B. (1992). Subclinical hepatic encephalopathy: Relationship between neuropsychological deficits and standard laboratory tests assessing hepatic status. Arch. Clin. Neuropsychol. 7:419-429.
41. Mousseau, D.D., and Butterworth, R.F. (1994). The {3H} Tryptamine Receptor in Human Brain: Kinetics, Distribution, and Pharmacologic Profile. J. Neurochem. 63:1052-1059.
42. Mousseau, D.D., Layrargues, G.P., and Butterworth, R.F. (1994). Region-selective decreases in densities [3H] tryptamine binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J. Neurochem. 46:869-874.
43. Munoz, M.D., Monfort, P., Gaztelu, J.M., and Felipo, V. (2000). Hyperammonemia impairs NMDA receptor-dependent long-term potentiation in the CA1 of rat hippocampus in-vitro. Neurochem. Res. 25:437-441.
44. Naegele, T., Grodd, W., Viebahn, R., Seeger, U., Klose, U., Seitz, D., Kaiser, S., Mader, I., Mayer, J. Lauchart, W., Gregor, M., and Voigt, K. (2000). MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: Time-course of renormalization after liver transplantation. Radiology 216: 683-691.
45. Nolte, W., Wiltfang, J., Schindler, C., Munke, H., Unterberg, K., Zumhasch, U., Figulla, H.R., Werner, G., Hartmann, H., and Ramadori, G. (1998). Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology 28(5):1215-1225.
46. Norenberg, M., Itzhak, Y., Bender, A.S., Baker, L., Aguila-Mansilla, H.N., Zhou, B.-G., and Isaacks, R. (1998). Liver and Nervous System. Proceedings of the Falk Symposium No. 103, Falk Symposium, Freiberg, Kluwer Austin.
47. O'Carroll, R.E., Couston, M., Cossar, J., Masterton, G., and Hayes, P.C. (2003). Psychological outcome and quality of life following liver transplantation: A prospective, national, single-center study. Liver Transpl. 9(7):712-720.
48. Pantiga, C., Rodrigo, L.R., Cuesta, M., Lopez, L., Arias, J. L., and Pujol, A. (2003). Cognitive deficits in patients with hepatic cirrhosis and in liver transplant recipients. J. Neuropsychiatr. Clin. Neurosci. 15(1):84-89.
49. Parsons-Smith, B.S., Summerskill, W.H.J., Dawson, A.M., and Sherlock, S. (1957). The electroencephalograph in liver disease. Lancet. 2:867-871.
50. Pujol, A., Pujol, J., Graus, F., Rimola, A., Peri, J., Mercader, J.M., Garcia-Pagan, J.C., Bosch, J., Rodes, J., and Tolosa, E. (1993). Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 43(1):65-69.
51. Rama Rao, K.V., Jayakumar, A.R., and Norenberg, M.D. (2003). Induction of the mitochondrial permeability transition in cultured astrocytes by glutamine. Neurochem. Int. 43(4-5):517-523.
52. Rao, R.K., and Norenberg, M.D. (2004). Manganese induces the mitochondrial permeability transition in cultured astrocytes. J. Biol. Chem. 279(31):32333-32338.
53. Rao, V.L., and Butterworth, R.F. (1994). Alterations of [3H]8-OH-DPAT and [3H]ketanserin binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurosci Lett. 182(1):69-72.
54. Ratcliffe, J., Longworth, L., Young, T., Bryan, S., Burroughs, A., and Buxton, M. (2002). Assessing health-related quality of life pre- and post-liver transplantation: A prospective multicenter study. Liver Transpl. 8(3):263-270.
55. Rehnstrom, S., Simert, G., Hansson, J.A., Johnson, G., and Vang, J. (1977). Chronic hepatic encephalopathy. A psychometrical study. Scand. J. Gastroenterol. 12(3):305-311.
56. Rikkers, L., Jenko, P., Rudman, D., and Freides, D. (1978). Subclinical hepatic encephalopathy: Detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 75(3):462-469.
57. Rose, C., Butterworth, R.F., Zayed, J., Normandin, L., Todd, K., Michalak, A., Spahr, L., Huet, P.M., and Pomier-Layrargues, G. (1999). Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 117(3):640-644.
58. Sanyal, A.J., Freedman, A.M., Luketic, V.A., Purdum, P.P., 3rd, Shiffman, M.L., Cole, P.E., Tisnado, J., and Simmons, S. (1997). Transjugular intrahepatic portosystemic shunts compared with endoscopie sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann. Int. Med. 126(11):849-857.
59. Schliess, F., Gorg, B., Fischer, R., Desjardins, P., Bidmon, H.J., Herrmann, A., Butterworth, R.F., Zilles, K., and Haussinger, D. (2002). Ammonia induces MK-801-sensitive nitration and phosphorylation of protein tyrosine residues in rat astrocytes. Faseb J. 16(7):739-741.
60. Schomerus, H., Hamster, W., Blunck, H., Reinhard, U., Mayer, K., and Doyle, W. (1981). Latent portasystemic encephalopathy. In nature of cerebral functional defects and their effect on fitness to drive. Digestive Diseases and Sciences 28:622-630.
61. Schomerus, H., and Hamster, W. (1998). Neuropsychological aspects of portal-systemic encephalopathy. Metab. Brain Dis. 13(4):361-377.
62. Schomerus, H., and Hamster, W. (2001). Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab. Brain Dis. 16(1/2):37-41.
63. Shawcross, D.L., Davies, N.A., Williams, R., and Jalan, R. (2004). Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J. Hepatol. 40(2):47-254.
64. Spahr, L., Butterworth, R.F., Fontaine, S., Bui, L., Therrien, G., Milette, P.C., Lebrun, L.H., Zayed, J., Leblanc, A., and Pomier-Layrargues, G. (1996). Increased blood manganese in cirrhotic patients: Relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 24(5):1116-1120.
65. Suarez, I., Bodega, G., Arilla, E., and Fernandez, B. (1996). Long-term changes in glial fibrillary acidic protein and glutamine synthetase immunoreactivities in the supraoptic nucleus of portacaval shunted rats. Metab. Brain Dis. 11(4):369-379.
66. Tarbuck, A.F., and Paykel, E.S. (1995). Effects of major depression on the cognitive function of younger and older subjects. Psychol. Med. 25(2):285-295.
67. Tarter, R.E., and Van Thiel, D.H. (2001). Neuropsychological dysfunction due to liver disease. In: Tarter, R.E., and Butters, M., et al. (Eds.). Medical neuropsychology (2nd ed.). Kluwer Academic Publishers, Dordrecht, Netherlands, x, 346 pp.
68. Tarter, R.E., Hegedus, A.M., Van Thiel, D.H., Edwards, N., and Schade, R.R. (1987). Neurobehavioral correlates of cholestatic and hepatocellular disease: Differentiation according to disease specific characteristics and severity of the identified cerebral dysfunction. Int. J. Neurosci. 32(3/4):901-910.
69. Tarter, R.E., Hegedus, A.M., Van Thiel, D.H., Edwards, N., and Schade, R.R. (1984). Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology 86(6):421-1427.
70. Tarter, R., Hegedus, A., Van Thiel, D., Gavaler, J., and Schade, R. (1986). Hepatic dysfunction and neuropsychological test performance in alcoholics with cirrhosis. J. Studies Alcohol 47:74-77.
71. Tarter, R.E., Sandford, S.L., Hays, A.L., Carra, J.P., and Van Thiel, D.H. (1989). Hepatic injury correlates with neuropsychologic impairment. Int. J. Neurosci. 44(1-2):75-82.
72. Tarter, R.E., Switala, J.A., Arria, A., Plail, J., and Van Thiel, D.H. (1990). Subclinical hepatic encephalopathy. Comparison before and after orthotopic liver transplantation. Transplantation 50(4):632-637.
73. Van Thiel, D.H., Schade, R.R., Starzl, T.E., Iwatsuki, S., Shaw, B.W., Jr., Gavaler, J.S., and Dugas, M. (1982). Liver transplantation in adults. Hepatology 2(5):637-640.
74. Weissenborn, K., Ehrenheim, C., Hori, A., Kubicka, S., and Manns, M.P. (1995). Pallidal lesions in patients with liver cirrhosis: Clinical and MRI evaluation. Metab. Brain Dis. 10(3):219-231.
75. Weissenborn, K., Heidenreich, S., Giewekemeyer, K., Ruckert, N., Hecker, H., Young, S.N., and Lal, S. (2003). Memory function in early hepatic encephalopathy. J. Hepatol. 39(3):320-325.
76. Young, S.N., and Lal, S. (1980). CNS tryptamine metabolism in hepatic coma. J. Neurol. Transmission 47:153-161.